Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 4/20 | 0.31 |
| ▸ | CHRM5 | P08912 | 4/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | HBB | P68871 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.30 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL501039 | 0.81 | — | — | |
| SCHEMBL1499148 | 0.77 | — | — | |
| SCHEMBL28640210 | 0.77 | — | — | |
| SCHEMBL14524860 | 0.77 | — | — | |
| SCHEMBL12996951 | 0.77 | — | — | |
| SCHEMBL25457615 | 0.77 | — | — | |
| SCHEMBL7932112 | 0.76 | — | — | |
| SCHEMBL18628021 | 0.73 | ALDH1A1 (0.42) | ALDH1A1TDP1TSHRSMN1; SMN2TP53 | |
| Ethylene SCHEMBL6884384 | 0.73 | — | — | |
| SCHEMBL10448932 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2356160-B1 | ACRYLATED EPOXY-AMINE OLIGOMERS | SUN CHEMICAL BV (NL) | 2019-05-22 | — | — | EP | disclosed |
| CN-107430228-A | Optical film and method for producing optical film | 柯尼卡美能达株式会社 | 2017-12-01 | — | — | CN | disclosed |
| CN-101160112-B | Oral care compositions, regimens and devices | PROCTER & GAMBLE | 2012-05-02 | — | — | CN | disclosed |
| US-20080176820-A1 | Use of L-alpha-lysophosphatidylcholine to obtain the differentiation of monocytes into mature dendritic cells in vitro | BIOMERIEUX (FR) | 2008-07-24 | — | — | US | disclosed |
| US-7368287-B2 | Use of L-α-lysophosphatidylcholine to obtain the differentiation of monocytes into mature dendritic cells in vitro | BIOMERIEUX (FR) | 2008-05-06 | — | — | US | disclosed |
| CN-101160112-A | Oral care compositions, regimens and devices | PROCTER & GAMBLE (US) | 2008-04-09 | — | — | CN | disclosed |
| US-20050054095-A1 | Use of l-$g(a)-lysophosphatidylcholine to obtain the differentiation of monocytes in mature dendritic cells in vivo | BIO MERIEUX (FR) | 2005-03-10 | — | — | US | disclosed |
| US-4479782-A | Visible light-cured orthodontic adhesive | SCIENTIFIC PHARMACEUTICALS, INC. (US) | 1984-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080176820-A1 | Use of L-alpha-lysophosphatidylcholine to obtain the differentiation of monocytes into mature dendritic cells in vitro | CD14, LPCAT1, MYADM | ALDH1A1 2777/4885TDP1 4246/4885TSHR 4604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.